Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.22−0.34 (-3.97%)
Close on Nov 20, 2026Market cap $3.08BP/E –Yield –
Bausch Health Companies gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Bausch Health Companies's gross profit for the twelve months ending Jun 30, 2018 was $6.07B, down 9.4% year over year. For fiscal 2017 it was $6.22B, down 12.4% from the year before. The highest annual figure on record is $7.92B in fiscal 2015.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $6.22B | -12.4% |
| FY2016 | Dec 31, 2016 | $7.10B | -10.3% |
| FY2015 | Dec 31, 2015 | $7.92B | +31.3% |
| FY2014 | Dec 31, 2014 | $6.03B | +53.6% |
| FY2013 | Dec 31, 2013 | $3.92B | +52.3% |
| FY2012 | Dec 31, 2012 | $2.58B | +47.7% |
| FY2011 | Dec 31, 2011 | $1.74B | +121.9% |
| FY2010 | Dec 31, 2010 | $785.64M | +27.5% |
| FY2009 | Dec 31, 2009 | $616.12M | +10.0% |
| FY2008 | Dec 31, 2008 | $560.01M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | $1.54B | -3.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.44B | -5.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.53B | -12.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.57B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.60B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.53B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.75B | – |
See a number that looks wrong?